PT Kimia Farma (Persero) Tbk

Jakarta Stock Exchange KAEF.JK

PT Kimia Farma (Persero) Tbk EBT Margin for the year ending December 31, 2023: -21.75%

PT Kimia Farma (Persero) Tbk EBT Margin is -21.75% for the year ending December 31, 2023, a -4,310.93% change year over year. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.

PT Kimia Farma (Persero) Tbk EBT Margin for the year ending December 31, 2022 was 0.52%, a -83.09% change year over year.
PT Kimia Farma (Persero) Tbk EBT Margin for the year ending December 31, 2021 was 3.06%, a 316.79% change year over year.
PT Kimia Farma (Persero) Tbk EBT Margin for the year ending December 31, 2020 was 0.73%, a 79.87% change year over year.
PT Kimia Farma (Persero) Tbk EBT Margin for the year ending December 31, 2019 was 0.41%, a -94.74% change year over year.

Key data

Date	EBT Margin	Net Income Margin	EBITDA Margin	EBIT Margin

Jakarta Stock Exchange: KAEF.JK

PT Kimia Farma (Persero) Tbk

CEO	Mr. David Utama
IPO Date	July 5, 2001
Location	Indonesia
Headquarters	Jl. Veteran No.9
Employees	10,712
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

PT Kimia Farma (Persero) Tbk produces and sells medicines, herbal medicines, iodine, salts, quinine and their derivative products, and vegetable oils in Indonesia. The company operates through Manufacturing, Distribution, Retail, and Other Services segments. It also manufactures and sells generic, ethical, license and narcotic medicines, and over the counter medicines, health equipment, raw materials, medicines, medical devices, and cosmetics. In addition, the company distributes its products in drug to pharmacies, hospital pharmacy installation, medical center, and drug stores. The company was founded in 1817 and is headquartered in Jakarta, Indonesia.

Key trends

Past 5 years